Entropy Technologies’s Pfizer PFE Stock Holding History

Entropy Technologies’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-108,300	Closed	-$2.76M	–	1098
2025 Q3	$2.76M	Sell	108,300 -428,933	-80%	-$10.6M	0.21%	139
2025 Q2	$13M	Buy	537,233 +350,000	+187%	+$8.16M	1.03%	4
2025 Q1	$4.74M	Sell	187,233 -284,653	-60%	-$7.45M	0.46%	47
2024 Q4	$12.5M	Buy	471,886 +442,175	+1,488%	+$12M	1.29%	2
2024 Q3	$860K	Buy	+29,711	New	+$867K	0.09%	301

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Entropy Technologies's PFE Position: Q4 2025 in Review

Entropy Technologies sold out of Pfizer (PFE) in Q4 2025, closing a stake of 108,300 shares — an estimated $2.76M sold.

Entropy Technologies first reported a position in PFE in Q3 2024 and held it in 5 quarters. The position peaked at $13M in Q2 2025. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Entropy Technologies reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
Entropy Technologies sold 108,300 Pfizer shares in Q4 2025, an estimated $2.76M.
Entropy Technologies first reported a position in Pfizer in Q3 2024 and held it in 5 quarters.
Entropy Technologies's Pfizer position peaked at $13M in Q2 2025.
2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Entropy Technologies's 13F filing for Q4 2025, filed 13 Feb 2026.